Synergistic Effects of Phage–Antibiotic Combinations against Citrobacter amalonaticus
Open Access
- 3 January 2022
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 8 (1) , 59-65
Abstract
Non-antibiotic alternative treatments to combat the increasing number of infections caused by multidrug resistant bacteria are urgently needed. In recent years, bacteriophages have reemerged to potentially replace or complement the role of antibiotics, as bacterial viruses have the ability to inactivate pathogens. This study aimed to evaluate the synergy of phage–antibiotic combinations. A Citrobacter amalonaticus isolate was used in this study together with the phage MRM57. Eight different antibiotics with different mechanisms of action were used in combination with the phage to study the impact of the combination treatment on the minimal inhibitory concentrations. We found that antibiotic concentration dependent synergism exists, albeit at different extents, with very low numbers of phages. This demonstrates the use of phages as an adjuvant with a sublethal concentration of antibiotics as an effective therapeutic strategy.Keywords
Funding Information
- VIT University
This publication has 32 references indexed in Scilit:
- Phage Cocktails and the Future of Phage TherapyFuture Microbiology, 2013
- The multifaceted roles of antibiotics and antibiotic resistance in natureFrontiers in Microbiology, 2013
- Phage therapyBacteriophage, 2013
- Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosaResearch in Microbiology, 2013
- Synergistic phage-antibiotic combinations for the control ofEscherichia colibiofilmsin vitroFEMS Immunology & Medical Microbiology, 2012
- Enhanced Staphylolytic Activity of the Staphylococcus aureus Bacteriophage vB_SauS-phiIPLA88 HydH5 Virion-Associated Peptidoglycan Hydrolase: Fusions, Deletions, and Synergy with LysH5Applied and Environmental Microbiology, 2012
- Basic Phage Electron Microscopy2009
- Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage GrowthPLOS ONE, 2007
- Synergistic Killing of Streptococcus pneumoniae with the Bacteriophage Lytic Enzyme Cpl-1 and Penicillin or Gentamicin Depends on the Level of Penicillin ResistanceAntimicrobial Agents and Chemotherapy, 2005
- The fractional inhibitory concentration (FIC) index as a measure of synergyJournal of Antimicrobial Chemotherapy, 1983